Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity
about
Factors in AIDS dementia complex trial design: results and lessons from the abacavir trialMycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityDrug interactions and antiretroviral drug monitoring.Renal transplantation in patients with HIV.Living related donor renal transplant in human immunodeficiency virus infected patient: case reports from tertiary care hospital in Western IndiaLiver transplantation in HCV/HIV positive patients.Kidney disease in children and adolescents with perinatal HIV-1 infection.Renal transplantation between HIV-positive donors and recipients justified.Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.Perspectives on liver and kidney transplantation in the human immunodeficiency virus-infected patient.Solid organ transplants in HIV-infected patients.Antiviral drug discovery: broad-spectrum drugs from nature.In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil.HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
P2860
Q28469174-321EE01D-8403-48A2-BDC3-A5911FE1A1D9Q33781206-73A739AC-CFC0-45A7-95FA-13DAA131ECA7Q34021173-21A549F5-8DED-46B5-B5F3-459853A0331CQ34079397-17E394FE-455B-43CB-A057-8BD670FDB1A0Q34101413-4E4CCFBF-5545-4B49-90B5-2DB240B8C4B3Q34640985-FFBCC682-681F-44F4-8757-A00DBE306164Q36942310-C3D5B6D5-1FBB-4632-AEB3-4EF5C74EC712Q37401425-7FCA4206-522A-4EFC-B718-C1A5600689A0Q37421895-294ADC32-217B-4200-BCFB-5E0AC8FDFF16Q38109986-1DC43C48-A41F-4C97-8035-D0A3DAFED31EQ38124737-E2A60103-8F28-4985-9947-5A6A0D19320BQ38260235-CCF66278-7A34-4ACB-A187-E44D2D3D9A5EQ40291210-5D129722-13CC-437A-8F4D-1C85CEC63B04Q40551606-5958EF9D-9088-4280-A670-B04DED2212A3Q41857320-34870C15-BB0D-497C-A82E-7C10FF978070Q46757223-B3946528-E8FF-4D4D-AA0B-54BEC0AF4DFE
P2860
Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@ast
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@en
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@nl
type
label
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@ast
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@en
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@nl
prefLabel
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@ast
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@en
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@nl
P2093
P1476
Abacavir and mycophenolic acid ...... synergistic anti-HIV activity
@en
P2093
P304
P356
10.1097/00042560-199908150-00002
P407
P577
1999-08-15T00:00:00Z